Contact

Click here for a confidential contact or call:

1-212-350-2774

FCA Federal

This archive displays posts tagged as relevant to the federal False Claims Act. You may also be interested in the following pages:

Page 176 of 182

EMC - Procurement Fraud/Education ($95.5 million)

A Constantine Cannon attorney represented two whistleblowers in a False Claims Act case alleging Education Management Corporation violated the recruiter incentive compensation ban, enrolling students regardless of whether they were suitable candidates.  In November 2015, the company agreed to pay $95.5 million to settle the action, the largest False Claims Act settlement to date involving the Department of Education.  The two whistleblowers (along with several others) received a whistleblower award of $11.3 million.  Read more -- Business InsiderDOJ, PR Newswire, CC.

Constantine Cannon Whistleblower Suit Against KBR Will Go Forward: False Certification of Compliance Not Needed To State a Claim

Posted  10/21/15
C|C Whistleblower Team By Janice Kelly A whistleblower suit against KBR will go forward after a district court judge found that relators’ complaint sufficiently alleged a violation of the False Claims Act. Judge Michael M. Mihm found that relators’ claims that KBR sidestepped required inventory controls and ordered hundreds of millions of dollars of unneeded materials met the FCA’s requirement that fraud...

DOJ Catch Of The Week -- Technology Integration Group

Posted  08/14/15
By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to PC Specialists Inc., doing business as Technology Integration Group (TIG).  On Tuesday, the San-Diego-based computer supply company agreed to pay $5.9 million to settle charges it inflated the price of computers sold through another company to the National Nuclear Security Administration (NNSA) for use at Sandia...

Court Slaps Down DOJ For Skimping On Whistleblower Award

Posted  07/24/15
By Gordon Schnell It is a rare occasion where the Department of Justice gets judicially censured for shortchanging a whistleblower under the qui tam provisions of the False Claims Act.  But that is exactly what District Court Judge Robert F. Kelly (Eastern District Pennsylvania) did last week in United Sates ex rel. Ryan v. Endo Pharmaceuticals, Inc.  There, Judge Kelly came down hard on the government for...

Ninth Circuit Victory For Whistleblowers In Narrowing "Public Disclosure" And "First-To-File" Bars To Bringing Qui Tam Actions

Posted  07/10/15
By Gordon Schnell
In a major victory for whistleblowers, the Ninth Circuit in United States ex rel. Hartpence v. Kinetic Concepts, Inc. narrowed the reach of two significant bars to bringing qui tam lawsuits under the False Claims Act.  Under the so-called "public disclosure" bar, the Ninth Circuit reversed its own precedent and ruled the "original source" exception to the bar does not require the whistleblower to have played a role...

DOJ Catch Of The Week -- VMware & Carahsoft Technology

Posted  07/2/15
By the C|C Whistleblower Lawyer Team This week's Department of Justice "catch of the week" goes to VMware Inc. and Carahsoft Technology Corporation.  On Tuesday, the two companies agreed to pay $75.5 million to settle charges they violated the False Claims Act by misrepresenting their commercial pricing practices and overcharging the government on VMware software products and related services.  Palo Alto-based...

DOJ Gives Major Shoutout To Whistleblowers In $450M DaVita False Claims Act Settlement

Posted  06/26/15
By Gordon Schnell On Wednesday, Denver-based provider of dialysis services DaVita Healthcare Partners, Inc. agreed to pay $450 million to resolve charges it violated the False Claims Act by purposely creating and then billing the government for unnecessary waste in administering the drugs Zemplar and Venofer to dialysis patients.  DaVita is the largest provider of dialysis services in the US with dialysis clinics...

June 24, 2015

Dr. Alon Vanier and nurse Daniel Barbir will receive a very sizeable whistleblower award from the $450 million DaVita Healthcare Partners, Inc. agreed to pay to settle charges it violated the False Claims Act by purposely creating and then billing the government for unnecessary waste in administering the drugs Zemplar and Venofer to dialysis patients.

DOJ Catch Of The Week -- Hebrew Homes Health Network

Posted  06/19/15
By the C|C Whistleblower Lawyer Team This week's Department of Justice "catch of the week" goes to Hebrew Homes Health Network Inc., a Florida-based operator of rehabilitation and skilled nursing facilities.  On Tuesday, the company -- along with its former president and executive director William Zubkoff -- agreed to pay $17 million to resolve allegations it violated the False Claims Act by improperly paying...

June 18, 2015

47 states and the District of Columbia reached a settlement with Inspire Pharmaceuticals, resolving allegations that Inspire violated state and federal False Claims Act laws by illegally marketing the drug Azasite for off-label uses not approved by the U.S. Food and Drug Administration. Approved only for the treatment of bacterial conjunctivitis (“pink eye”), Inspire marketed Azasite for the treatment of blepharitis, an inflammation of the eyelash follicles. While physicians are permitted to prescribe drugs for conditions other than those for which the drugs have been approved by the FDA, pharmaceutical companies are prohibited from marketing drugs to physicians for such off label conditions. It is contended that, as a result of Inspire’s illegal off label promotion, Inspire caused the submission of false and fraudulent claims for Azasite to the Medicaid program and other federal programs. NY
1 174 175 176 177 178 182